Diniz-Freitas M, López-Cedrún JL, Fernández-Sanromán J, García-García A, Fernández-Feijoo J, Diz-Dios P. Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain. Med Oral Patol Oral Cir Bucal. 2012 Sep 1;17 (5):e751-8. 

 

doi:10.4317/medoral.18041

http://dx.doi.org/doi:10.4317/medoral.18041

 

 

1. Lin JT, Lane JM. Osteoporosis: a review. Clin Orthop Relat Res. 2004;425:126-34.
http://dx.doi.org/10.1097/01.blo.0000132404.30139.f2
PMid:15292797

2. Erviti J. Drug prescription for osteoporosis. An Sist Sanit Navar. 2003;26:107-21.
PMid:14716363

3. Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367:2010-8.
http://dx.doi.org/10.1016/S0140-6736(06)68891-0

4.
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369-76.
http://dx.doi.org/10.1016/j.joms.2006.11.003
PMid:17307580

5. Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, et al.
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res. 2011;90:439-44.
http://dx.doi.org/10.1177/0022034510397196
PMid:21317246    PMCid:3144129

6. Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, et al. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence - a multi-centre study. J Craniomaxillofac Surg. 2011;39:272-7.
http://dx.doi.org/10.1016/j.jcms.2010.05.009
PMid:20580566

7.
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67:2-12.
http://dx.doi.org/10.1016/j.joms.2009.01.009
PMid:19371809

8. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1

9.
Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007;65:415-23.
http://dx.doi.org/10.1016/j.joms.2006.10.061
PMid:17307586

10. Marx RE, Cillo JE Jr, Ulloa JJ.
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-410.
http://dx.doi.org/10.1016/j.joms.2007.08.003
PMid:18022461

11. Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis. Int J Oral Maxillofac Surg. 2011;40:277-84.
http://dx.doi.org/10.1016/j.ijom.2010.11.002
PMid:21163625

12. Hong JW, Nam W, Cha IH, Chung SW, Choi HS, Kim KM, et al. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int. 2010;21:847-53.
http://dx.doi.org/10.1007/s00198-009-1024-9
PMid:19633881

13. Favia G, Pilolli GV, Maiorano E. Osteonecrosis of the jaw correlated to bisphosphonate therapy in Non-oncologic patients: Clinicopathologicl features of 24 patients. J Rheumatol. 2009;26:2780-7.
http://dx.doi.org/10.3899/jrheum.090455
PMid:19884275

14. Lo JC, O’Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010;68:243-53.
http://dx.doi.org/10.1016/j.joms.2009.03.050
PMid:19772941

15. Kwon YD, Kim DY, Ohe JY, Yoo JY, Walter C. Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:2644-8.
http://dx.doi.org/10.1016/j.joms.2009.04.067
PMid:19925985

16. Williamson RA. Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg. 2010;39:251-5.
http://dx.doi.org/10.1016/j.ijom.2009.11.014
PMid:20015614

17. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg. 2009;67:850-5.
http://dx.doi.org/10.1016/j.joms.2008.11.015
PMid:19304045

18. Barrier A, Lescaille G, Rigolet A, Descroix V, Goudot P, Ruhin B. Jaw osteonecrosis induced by oral bisphosphonates: 12 cases. Rev Stomatol Chir Maxillofac. 2010;111:196-202.
http://dx.doi.org/10.1016/j.stomax.2010.07.009
PMid:20810140

19. Chiu CT, Chiang WF, Chuang CY, Chang SW. Resolution of oral bisphosphonate andsteroid-related osteonecrosis of the jaw--a serial case analysis. J Oral Maxillofac Surg. 2010;68:1055-63.
http://dx.doi.org/10.1016/j.joms.2009.12.030
PMid:20403529

20. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int. 2007;18:1363-70.
http://dx.doi.org/10.1007/s00198-007-0384-2
PMid:17598065

21. Hutchinson M, O’Ryan F, Chavez V, Lathon PV, Sanchez G, Hatcher DC, et al. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.
J Oral Maxillofac Surg. 2010;68:2232-40.
http://dx.doi.org/10.1016/j.joms.2010.05.003
PMid:20728032

22. Bagán JV, Murillo J, Jiménez Y, Poveda R, Milián MA, Sanchís JM, et al.
Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med. 2005;34:120-3.
http://dx.doi.org/10.1111/j.1600-0714.2004.00269.x
PMid:15641993

23. Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA, et al. Updated Recommendations for Managing the Care of Patients Receiving Oral Bisphosphonate Therapy: An Advisory Statement From the American Dental Association Council on Scientific Affairs. JADA. 2008;139:1674-7.
PMid:19047674

24. Palaska PK, Cartsos V, Zavras AI. Bisphosphonates and time to osteonecrosis development. Oncologist. 2009;14:1154-66.
http://dx.doi.org/10.1634/theoncologist.2009-0115
PMid:19897878

25. Grana J, Mahia IV, Meizoso MO, Vazquez T. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis). Clin Exp Rheumatol. 2008;26:384-5.
PMid:18565271

26. Tankó LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res. 2005;20:1912-20.
http://dx.doi.org/10.1359/JBMR.050711
PMid:16234963

27. Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, et al.
Possible association between diabetes and bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab. 2007;92:1172-5.
http://dx.doi.org/10.1210/jc.2006-2036

28.
Valdés S, Rojo-Martínez G, Soriguer F. [Evolution of prevalence of type 2 diabetes in adult Spanish population]. Med Clin (Barc). 2007;129:352-5.
http://dx.doi.org/10.1157/13109554

29.
de Paula FJ, Horowitz MC, Rosen CJ. Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev. 2010;26:622-30.
http://dx.doi.org/10.1002/dmrr.1135
PMid:20938995    PMCid:3259009

30. Neto NC, de Souza Bastos A, Chierici-Marcantonio RA, Marcantonio E Jr.
Is rheumatoid arthritis a risk factor for oral bisphosphonate-induced osteonecrosis of the jaws?. Med Hypotheses. 2011;77:905-11.
http://dx.doi.org/10.1016/j.mehy.2011.08.008
PMid:21885199

31. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol. 2009;45:164-72.
http://dx.doi.org/10.1016/j.oraloncology.2008.04.013
PMid:18715819

32. Hikita H, Miyazawa K, Tabuchi M, Kimura M, Goto S. Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats. J Bone Miner Metab. 2009;27:663-72.
http://dx.doi.org/10.1007/s00774-009-0090-6
PMid:19436946

33. Kim RH, Lee RS, Williams D, Bae S, Woo J, Lieberman M, et al. Bisphosphonates induce senescence in normal human oral keratinocytes. J Dent Res. 2011;90:810-6.
http://dx.doi.org/10.1177/0022034511402995
PMid:21427353    PMCid:3144120

34. Kyrgidis A, Vahtsevanos K. Increased risk for bisphosphonate-related osteonecrosis of the jaws in patients wearing dentures could be attributable to impaired mucosal cell wound healing. J Oral Maxillofac Surg. 2009;67:1355-6.
http://dx.doi.org/10.1016/j.joms.2008.05.368
PMid:19446234

35. Kunchur R, Goss AN. The oral health status of patients on oral bisphosphonates for osteoporosis. Aust Dent J.2008;53:354-7.
http://dx.doi.org/10.1111/j.1834-7819.2008.00078.x
PMid:19133952